Custom Search
FDA Information
Abciximab (previously known as c7E3 Fab), is manufactured by Centocor and distributed by Eli Lilly under the trade name ReoPro®.
Abciximab is an FDA approved medication for patients undergoing elective PCI with a stent, or with an acute coronary syndrome (unstable angina or non-ST elevation MI). More than 2 million patients have been treated worldwide with abciximab since its approval by the FDA in 1994.
Please visit the official site of the FDA for further information.
Why is this medication prescribed?
Dosage and using this medicine
What special precautions should I follow?
What should I do if I forget a dose?
What side effects can this medication cause?